Product

IASOflu

iasoflu 1

Marketing Authorizations

Country
Product Name
MA number
Date of registration
PDF
France
IASOflu
34009 578 426 5 9 (15mL) 34009 573 228 0 9 (25mL)
21.07.2008
Austria
IASOfluorid
4-00043
20.10.2010
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
Germany
IASOflu
76609.00.00
22.11.2010
No data was found
No data was found
Italy
IASONfluoride
040986010 (15mL) 040986022 (25mL)
14.10.2013
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found

Sodium fluoride (¹⁸F) positron emission tomography (PET) is indicated for functional imaging in diseases where abnormally altered osteogenic activity is the diagnostic target.

Therapeutic indications

The following indications have been particularly documented:

  • Detection and localisation of bone metastases in case of cancer in adults.
  • As an aid in the evaluation of back pain of ambiguous origin in adults, when conventional imaging modalities are not conclusive.
  • As an aid in the detection of the presence of bone lesions related to suspected child abuse.
    This medicinal product is for diagnostic use only.

Therapeutic indications. This medicinal product is for diagnostic use only.

Do you want to know more about our products?

For inquiries please contact us, we will be happy to assist you!

Find out more about Curium’s global footprint

Scroll to Top
Iason Logo Alt
curium logo

Welcome to our new website

You've been redirected from iason.eu to our new domain curium-austria.com

Curium acquired IASON in June of 2021, further expanding its footprint in Europe for its broad portfolio of life saving diagnostic solutions. Learn more on Curium’s website